MyFinsight
Home
Blog
About
Twist Bioscience Corp (TWST)
Twist Bioscience Corp (TWST)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$5,286K
Free Cash flow
-$8,648K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Stock-based compensation expense
Proceeds from maturity of invest...
Accrued compensation
Others
Negative Cash Flow Breakdown
Net loss
Purchases of investments
Purchases of property and equipm...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-35,051
-44,021
-30,507
-27,138
Depreciation and amortization
6,778
6,414
6,194
6,004
Impairment of long-lived assets
-
-
-
0
Non-cash lease expense, net of tenant improvement allowance
-
-
-
-20
Stock-based compensation expense
18,176
18,936
13,273
16,083
Change in fair value of contingent considerations and holdbacks
-
-
-
0
Gain on sale of business
0
-
-
0
Other non-cash adjustments
-161
498
336
-240
Accounts receivable, net
1,085
14,238
-6,826
7,210
Inventories
1,647
590
4,615
2,368
Prepaid expenses and other current assets
99
11,126
7,735
1,895
Other non-current assets
-114
641
-225
965
Accounts payable
3,039
69
1,472
-284
Accrued expenses
-
-
1,509
2,317
Accrued compensation
7,869
8,168
-12,436
2,287
Other liabilities
-
-
1,316
1,135
Accrued expenses and other liabilities
2,860
22,793
-
-
Net cash used in operating activities
1,115
-17,559
-24,814
-11,814
Purchases of property and equipment
9,763
7,887
9,974
12,427
Purchase of intangible asset
0
100
-
-
Purchases of investments
13,235
4,718
20,509
21,136
Proceeds from maturity of investments
12,800
5,000
20,550
21,160
Proceeds from sale of business
0
-
-
0
Cash paid for asset acquisition
0
5,000
-
-
Cash paid for investment in equity securities
0
1
-
-
Net cash used in investing activities
-10,198
-12,706
-9,933
-12,403
Proceeds from exercise of stock options
3,793
1,789
300
3,792
Proceeds from the issuance of liability related to sale of future revenue
0
0
0
0
Proceeds from issuance under employee stock purchase plan
0
2,357
-
1,784
Repurchases of common stock for income tax withholding
6
8
2
2
Net cash provided by financing activities
3,787
4,138
298
5,574
Effect of exchange rates on cash, cash equivalents and restricted cash
10
-6
9
163
Net decrease in cash, cash equivalents, and restricted cash
-5,286
-26,133
-34,440
-18,480
Cash, cash equivalents, and restricted cash at beginning of period
150,985
150,985
185,425
229,132
Cash, cash equivalents, and restricted cash at end of period
119,566
124,852
150,985
185,425
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from exercise of
stock options
$3,793K
(-31.67%↓ Y/Y)
Stock-based compensation
expense
$18,176K
(-62.43%↓ Y/Y)
Accrued compensation
$7,869K
(267.71%↑ Y/Y)
Depreciation and
amortization
$6,778K
(-64.04%↓ Y/Y)
Accounts payable
$3,039K
(-68.40%↓ Y/Y)
Accrued expenses and
other liabilities
$2,860K
Other non-cash
adjustments
-$161K
(91.80%↑ Y/Y)
Other non-current
assets
-$114K
(-118.91%↓ Y/Y)
Net cash provided by
financing activities
$3,787K
(-83.51%↓ Y/Y)
Net cash used in
operating activities
$1,115K
(103.11%↑ Y/Y)
Effect of exchange
rates on cash, cash...
$10K
(150.00%↑ Y/Y)
Canceled cashflow
$6K
Canceled cashflow
$37,882K
Net decrease in
cash, cash...
-$5,286K
(79.05%↑ Y/Y)
Canceled cashflow
$4,912K
Proceeds from maturity of
investments
$12,800K
(-55.82%↓ Y/Y)
Repurchases of common stock
for income tax...
$6K
(-57.14%↓ Y/Y)
Net loss
-$35,051K
(30.64%↑ Y/Y)
Inventories
$1,647K
(-11.50%↓ Y/Y)
Accounts receivable, net
$1,085K
(-92.85%↓ Y/Y)
Prepaid expenses and
other current assets
$99K
(-94.57%↓ Y/Y)
Net cash used in
investing activities
-$10,198K
(17.49%↑ Y/Y)
Canceled cashflow
$12,800K
Purchases of investments
$13,235K
(-53.16%↓ Y/Y)
Purchases of property and
equipment
$9,763K
(-37.32%↓ Y/Y)
Buy us a coffee